In contrast to the study that revealed no differences in CCR2 expression in the most aggressive canine inflammatory mammary cancers compared to non-inflammatory tumors [69], we documented a significant increase in CCR2 expression in the metastatic cancers versus the benign and malignant non-metastatic tumors. The gene discussed is CCR2; the disease is breast cancer.